Arbutus Biopharma Corp — Director's Dealing 2014

Dec 31, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TEKMIRA PHARMACEUTICALS Corp (TKMR)
CIK: 0001447028
Period of Report: 2015-01-01

Reporting Person: KARBE FRANK (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	5000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Director Stock Option (Right to Buy)	$3.85	2020-01-27	Common Shares (5000)		Direct
Director Stock Option (Right to Buy)	$2.40	2021-08-09	Common Shares (5000)		Direct
Director Stock Option (Right to Buy)	$1.70	2021-12-22	Common Shares (5000)		Direct
Director Stock Option (Right to Buy)	$5.15	2022-12-09	Common Shares (5000)		Direct
Director Stock Option (Right to Buy)	$12.52	2024-05-07	Common Shares (17500)		Direct
Warrants	$2.60	2017-03-01	Common Shares (2500)		Direct

Footnotes

F1: Expressed in Canadian dollars.